<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK395975" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK395975/" /><meta name="ncbi_pagename" content="Primary Familial and Congenital Polycythemia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Primary Familial and Congenital Polycythemia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Primary Familial and Congenital Polycythemia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/11/10" /><meta name="citation_author" content="Celeste Bento" /><meta name="citation_author" content="Mary Frances McMullin" /><meta name="citation_author" content="Melanie Percy" /><meta name="citation_author" content="Holger Cario" /><meta name="citation_pmid" content="27831681" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK395975/" /><meta name="citation_keywords" content="ECYT1" /><meta name="citation_keywords" content="Familial Erythrocytosis Type 1" /><meta name="citation_keywords" content="Familial Erythrocytosis Type 1" /><meta name="citation_keywords" content="ECYT1" /><meta name="citation_keywords" content="Erythropoietin receptor" /><meta name="citation_keywords" content="EPOR" /><meta name="citation_keywords" content="Primary Familial and Congenital Polycythemia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Primary Familial and Congenital Polycythemia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Celeste Bento" /><meta name="DC.Contributor" content="Mary Frances McMullin" /><meta name="DC.Contributor" content="Melanie Percy" /><meta name="DC.Contributor" content="Holger Cario" /><meta name="DC.Date" content="2016/11/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK395975/" /><meta name="description" content="Primary familial and congenital polycythemia (PFCP) is characterized by isolated erythrocytosis in an individual with a normal-sized spleen and absence of disorders causing secondary erythrocytosis. Clinical manifestations relate to the erythrocytosis and can include plethora, the hyperviscosity syndrome (headache, dizziness, fatigue, lassitude, visual and auditory disturbances, paresthesia, myalgia), altered mental status caused by hypoperfusion and local hypoxia, and arterial and/or venous thromboembolic events. Although the majority of individuals with PFCP have only mild manifestations of hyperviscosity such as dizziness or headache, some affected individuals have had severe and even fatal complications including arterial hypertension, intracerebral hemorrhage, deep vein thrombosis, coronary disease, and myocardial infarction. To date 116 affected individuals from 24 families have been reported." /><meta name="og:title" content="Primary Familial and Congenital Polycythemia" /><meta name="og:type" content="book" /><meta name="og:description" content="Primary familial and congenital polycythemia (PFCP) is characterized by isolated erythrocytosis in an individual with a normal-sized spleen and absence of disorders causing secondary erythrocytosis. Clinical manifestations relate to the erythrocytosis and can include plethora, the hyperviscosity syndrome (headache, dizziness, fatigue, lassitude, visual and auditory disturbances, paresthesia, myalgia), altered mental status caused by hypoperfusion and local hypoxia, and arterial and/or venous thromboembolic events. Although the majority of individuals with PFCP have only mild manifestations of hyperviscosity such as dizziness or headache, some affected individuals have had severe and even fatal complications including arterial hypertension, intracerebral hemorrhage, deep vein thrombosis, coronary disease, and myocardial infarction. To date 116 affected individuals from 24 families have been reported." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK395975/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pfcp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK395975/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C13A1E04081E10000000004AF01B5.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK395975_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK395975_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/glc/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bgc/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK395975_"><span class="title" itemprop="name">Primary Familial and Congenital Polycythemia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ECYT1, Familial Erythrocytosis Type 1</div><p class="contrib-group"><span itemprop="author">Celeste Bento</span>, PhD, <span itemprop="author">Mary Frances McMullin</span>, MD, <span itemprop="author">Melanie Percy</span>, PhD, and <span itemprop="author">Holger Cario</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK395975_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK395975_ai__"><div class="contrib half_rhythm"><span itemprop="author">Celeste Bento</span>, PhD<div class="affiliation small">Department of Clinical Hematology<br />Centro Hospitalar e Universit&#x000e1;rio de Coimbra<br />Coimbra, Portugal<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tp.eduas-nim.cuhc@otneb.etselec" class="oemail">tp.eduas-nim.cuhc@otneb.etselec</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Mary Frances McMullin</span>, MD<div class="affiliation small">Department of Haematology<br />Queens University<br />Belfast, Northern Ireland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.buq@nillumcm.m" class="oemail">ku.ca.buq@nillumcm.m</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Melanie Percy</span>, PhD<div class="affiliation small">Department of Haematology<br />Belfast City Hospital<br />Belfast, Northern Ireland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.buq@ycrep.m" class="oemail">ku.ca.buq@ycrep.m</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Holger Cario</span>, MD<div class="affiliation small">Department of Paediatrics and Adolescent Medicine<br />University Medical Center Ulm<br />Ulm, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.mlu-kinilkinu@oirac.regloh" class="oemail">ed.mlu-kinilkinu@oirac.regloh</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 10, 2016</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pfcp.Summary" itemprop="description"><h2 id="_pfcp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> erythrocytosis in an individual with a normal-sized spleen and absence of disorders causing secondary erythrocytosis. Clinical manifestations relate to the erythrocytosis and can include plethora, the hyperviscosity syndrome (headache, dizziness, fatigue, lassitude, visual and auditory disturbances, paresthesia, myalgia), altered mental status caused by hypoperfusion and local hypoxia, and arterial and/or venous thromboembolic events. Although the majority of individuals with PFCP have only mild manifestations of hyperviscosity such as dizziness or headache, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had severe and even fatal complications including arterial hypertension, intracerebral hemorrhage, deep vein thrombosis, coronary disease, and myocardial infarction. To date 116 affected individuals from 24 families have been reported.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of PFCP is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> erythrocytosis (hemoglobin and hematocrit above the normal reference range when adjusted for age and sex), normal hemoglobin oxygen affinity measured as P<sub>50</sub>, erythropoietin (EPO) serum level below or in the lower normal range for laboratory-specific reference values, and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. The diagnosis of PFCP can be confirmed in 12%-15% of individuals with these findings by detection of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>EPOR</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> No management guidelines have been published. While the majority of individuals with PFCP require no regular treatment, some undergo phlebotomy to either treat symptoms of the hyperviscosity syndrome or to maintain the hematocrit at an almost normal level. Some patients require antihypertensive therapy. While low-dose aspirin can be considered for the prevention of thromboembolic events, no evidence of efficacy exists.</p><p><i>Prevention of primary manifestations:</i> Maintain good hydration and avoid activities that potentially increase blood viscosity (e.g., mountain climbing, scuba diving, smoking). For those at increased risk for thromboembolic events: take precautions in higher-risk situations such as long-distance airline flights</p><p><i>Surveillance:</i> Regular cardiology assessment including cardiac function (echocardiography) and blood pressure measurement. Life-long assessment for manifestations/severity of hyperviscosity syndrome and investigation of any suspicious clinical events such as thromboembolic complications.</p><p><i>Agents/circumstances to avoid:</i> Dehydration; activities that could increase blood viscosity (mountain climbing, scuba diving, smoking)</p><p><i>Evaluation of relatives at risk:</i> Presymptomatic diagnosis is warranted in relatives at risk in order to identify as early as possible those who would benefit from education about agents and circumstances to avoid including inappropriate treatments.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>PFCP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Each child of an individual with PFCP has a 50% chance of inheriting the <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Once the <i>EPOR</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for PFCP are possible options; note, however, that molecular genetic test results cannot predict disease onset or severity.</p></div></div><div id="pfcp.Diagnosis"><h2 id="_pfcp_Diagnosis_">Diagnosis</h2><p>The consensus recommendations for the diagnosis of absolute erythrocytosis in children established by the Network of Experts on the Molecular Diagnosis of Myeloproliferative Neoplasm (MPN) and MPN-related <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> diseases (MPNr) (MPN &#x00026; MPNr-Euronet) are mainly based on measurement of serum erythropoietin (EPO) level and hemoglobin oxygen affinity measured as P<sub>50</sub>. Definitive diagnosis requires identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (or variants) in one of the known genes [<a class="bk_pop" href="#pfcp.REF.cario.2013.1734">Cario et al 2013</a>].</p><div id="pfcp.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP) <b>should be suspected</b> in individuals with the following clinical findings, laboratory findings, and family history.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>No splenomegaly</div></li><li class="half_rhythm"><div>Absence of cardiac, pulmonary, and renal disease causing secondary erythrocytosis</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div>Complete blood count that shows <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> absolute erythrocytosis:</div><ul><li class="half_rhythm"><div class="half_rhythm">Normal platelet and white cell counts, which demonstrate non-involvement of other hematopoietic cell lines and confirm <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> erythrocytosis</div></li><li class="half_rhythm"><div class="half_rhythm">Hemoglobin and hematocrit in at least two separate blood counts performed at different times that are above the normal reference range (adjusted to age and sex) and confirm absolute erythrocytosis</div><div class="half_rhythm">Note: Absolute erythrocytosis is distinct from: (1) relative erythrocytosis, caused by severe reduction in plasma volume (e.g., due to diuretics or severe diarrhea) and (2) apparent erythrocytosis, caused by arterial hypoxemia (e.g., cigarette smoking, carbon monoxide poisoning, or sleep apnea) (reviewed in <a class="bk_pop" href="#pfcp.REF.mcmullin.2005.174">McMullin et al [2005]</a>).</div></li></ul></li><li class="half_rhythm"><div>Normal hemoglobin oxygen affinity measured as P<sub>50</sub> (i.e., the partial pressure of oxygen in the blood at which hemoglobin is 50% saturated)</div></li><li class="half_rhythm"><div>Erythropoietin (EPO) serum level that is below or in the lower normal range (based on laboratory-specific reference values), which excludes secondary erythrocytosis associated with an increased serum EPO level (see <a href="#pfcp.Differential_Diagnosis">Differential Diagnosis</a>)</div></li></ul><p><b>Family history.</b> Other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relatives in a pattern consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</p></div><div id="pfcp.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of PFCP <b>can be established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> when:</p><ul><li class="half_rhythm"><div class="half_rhythm">Clinical findings alone support the diagnosis (i.e., <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> absolute erythrocytosis, normal P<sub>50</sub>, EPO serum level below or in the lower normal range, and a positive family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance);</div><div class="half_rhythm">AND/OR</div></li><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>EPOR</i> is identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and has some (not all) suggestive findings.</div></li></ul><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> when clinical findings strongly support the diagnosis of PFCP or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> in those with suggestive, but not diagnostic, clinical findings:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis identifies a pathogenic <i>EPOR</i> variant in 12%-15% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> erythrocytosis and low serum EPO levels [<a class="bk_pop" href="#pfcp.REF.kralovics.2001.115">Kralovics &#x00026; Prchal 2001</a>, <a class="bk_pop" href="#pfcp.REF.rives.2007.674">Rives et al 2007</a>, <a class="bk_pop" href="#pfcp.REF.alsheikh.2008.1072">Al-Sheikh et al 2008</a>]. Use of <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> as a next step can be considered; however, to date no <i>EPOR</i> deletions or duplications causative of PFCP have been reported.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>EPOR</i> and the genes causing secondary erythrocytosis (<i>HBB</i>, <i>BPGM</i>, <i>VHL</i>, <i>EGLN1</i>, and <i>EPAS1</i>) (see <a href="#pfcp.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered, especially for probands who either represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence of PFCP in a family) and/or in whom secondary causes of erythrocytosis have not been excluded. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="pfcp.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Primary Familial Congenital Polycythemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK395975/table/pfcp.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pfcp.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EPOR</i></td><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%-15%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported to date</td></tr><tr><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_2 hd_h_pfcp.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">85%-88%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pfcp.TF.1.1"><p class="no_margin">See <a href="/books/NBK395975/#pfcp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="pfcp.TF.1.2"><p class="no_margin">See <a href="#pfcp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="pfcp.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="pfcp.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#pfcp.REF.kralovics.2001.115">Kralovics &#x00026; Prchal [2001]</a>, <a class="bk_pop" href="#pfcp.REF.rives.2007.674">Rives et al [2007]</a>, <a class="bk_pop" href="#pfcp.REF.alsheikh.2008.1072">Al-Sheikh et al [2008]</a></p></div></dd><dt>5. </dt><dd><div id="pfcp.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="pfcp.TF.1.6"><p class="no_margin">Because <i>EPOR</i> pathogenic variants are found in only 12%-15% of individuals with PFCP, mutation of at least one other yet-to-be-identified <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> may also be causative, such as one involved in the EPOR signaling pathway or an erythropoiesis-regulating pathway [<a class="bk_pop" href="#pfcp.REF.kralovics.2001.115">Kralovics &#x00026; Prchal 2001</a>, <a class="bk_pop" href="#pfcp.REF.jedlickova.2003.327">Jedlickova et al 2003</a>, <a class="bk_pop" href="#pfcp.REF.bourantas.2006.537">Bourantas et al 2006</a>]. One possible candidate gene is <i>SH2B3 (</i>encoding SH2B adapter protein 3) as <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>SH2B3</i> pathogenic variants have been detected in several individuals with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> erythrocytosis [<a class="bk_pop" href="#pfcp.REF.mcmullin.2016.248">McMullin &#x00026; Cario 2016</a>].</p></div></dd></dl></div></div></div></div></div><div id="pfcp.Clinical_Characteristics"><h2 id="_pfcp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pfcp.Clinical_Description"><h3>Clinical Description</h3><p>Primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> erythrocytosis. To date, PFCP caused by inherited pathogenic variants in <i>EPOR</i> has been reported in 116 individuals from 24 families [<a class="bk_pop" href="#pfcp.REF.bento.2014.15">Bento et al 2014</a>]. The little information available on its clinical presentation is derived from case reports and the experience of the authors.</p><p>Clinical manifestations of PFCP comprise plethora, arterial and venous thromboembolic events, and symptoms caused by increased blood viscosity leading to hypoperfusion and local hypoxia. The hyperviscosity syndrome is characterized by symptoms including headache, dizziness, fatigue, lassitude, visual and auditory disturbances, paresthesia, and myalgia, and may be associated with altered mental status. Of note, the majority of individuals with PFCP have only mild manifestations with hyperviscosity symptoms such as dizziness or headache.</p><p>PFCP has been detected &#x02013; either by chance or due to symptoms &#x02013; in several children ages six months to 16 years [<a class="bk_pop" href="#pfcp.REF.arcasoy.1997.4628">Arcasoy et al 1997</a>, <a class="bk_pop" href="#pfcp.REF.furukawa.1997.222">Furukawa et al 1997</a>, <a class="bk_pop" href="#pfcp.REF.percy.1998.407">Percy et al 1998</a>, <a class="bk_pop" href="#pfcp.REF.petersen.2004.537">Petersen et al 2004</a>, <a class="bk_pop" href="#pfcp.REF.rives.2007.674">Rives et al 2007</a>]. Patient hematocrits ranged from 57% to 63%. Clinical manifestations (present in some, but not all) were usually relatively mild (predominantly chronic headache and plethora) and relieved by phlebotomy (see <a href="#pfcp.Management">Management</a>).</p><p>In contrast, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had severe and even fatal clinical complications such as arterial hypertension, intracerebral hemorrhage, deep vein thrombosis, coronary disease, and myocardial infarction [<a class="bk_pop" href="#pfcp.REF.prchal.1995.1831">Prchal et al 1995</a>, <a class="bk_pop" href="#pfcp.REF.sokol.1995.15">Sokol et al 1995</a>, <a class="bk_pop" href="#pfcp.REF.kralovics.1997.2057">Kralovics et al 1997</a>, <a class="bk_pop" href="#pfcp.REF.kralovics.1998.124">Kralovics et al 1998</a>].</p><p>The age at diagnosis and the clinical findings vary even within the same family. The descriptions of reported families/cases are examples of the clinical variability observed in this disorder even within the same family.</p><p>One of the first families described with PFCP included four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in three generations who were subsequently found to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#pfcp.REF.prchal.1985.1208">Prchal et al 1985</a>, <a class="bk_pop" href="#pfcp.REF.kralovics.1998.124">Kralovics et al 1998</a>]:</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, who had extensive coronary artery disease and arterial hypertension, died at age 58 years from hemorrhagic stroke.</div></li><li class="half_rhythm"><div>Another family member had hypertension and a myocardial infarction at age 40 years.</div></li><li class="half_rhythm"><div>The father of a young girl (who initially appeared to be unaffected) had arterial hypertension beginning at age 20 years and one episode of deep vein thrombosis; as a young girl his daughter had a normal blood count but EPO hypersensitivity in erythroid precursor cells (similar to that observed in the 3 other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members).</div></li></ul><p>In another family, all three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals were found to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#pfcp.REF.rives.2007.674">Rives et al 2007</a>]:</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, a 14-year old boy, was diagnosed with erythrocytosis during evaluation by a pediatric endocrinologist for apparent gynecomastia.</div></li><li class="half_rhythm"><div>The mother had had confirmed erythrocytosis during childhood and adolescence; at age 27 years her hemoglobin had been 175 g/L. At the time of the diagnosis of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, her hemoglobin was normal; however, her low serum ferritin concentration and transferrin saturation suggested that iron deficiency could be the explanation for her normal hematologic findings.</div></li><li class="half_rhythm"><div>The brother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> had experienced a deep vein thrombosis at age 18 years. Additional hyperviscosity symptoms which occurred intermittently were relieved by phlebotomies.</div></li></ul><p>A large Finnish family with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> erythrocytosis (including an Olympic medalist in cross-country skiing) was found to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#pfcp.REF.de_la_chapelle.1993.4495">de la Chapelle et al 1993</a>].</p><p>In a family <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#pfcp.REF.sokol.1995.15">Sokol et al 1995</a>]:</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> experienced an occipital hemorrhage at age 29 years.</div></li><li class="half_rhythm"><div>His two daughters developed asymptomatic erythrocytosis.</div></li><li class="half_rhythm"><div>His mother reported headaches and feeling &#x0201c;sluggish,&#x0201d; but had not experienced cerebral or coronary vascular accidents.</div></li></ul><p>A pathogenic <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant, predicted to result in the shortest truncated EPOR reported to date, was identified in a woman age 30 years followed since childhood for asymptomatic erythrocytosis of unknown cause. Her hemoglobin was 206 g/L, her hematocrit was 61%, and serum EPO level was low; she did not have splenomegaly [<a class="bk_pop" href="#pfcp.REF.chauveau.2016.475">Chauveau et al 2016</a>].</p><p><i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> were found in a man age 35 years who required regular phlebotomy and in a person age 52 years with a clinical history of recurrent venous thrombosis but no family history of hematologic disorders [<a class="bk_pop" href="#pfcp.REF.bento.2013.361">Bento et al 2013</a>, <a class="bk_pop" href="#pfcp.REF.chauveau.2016.475">Chauveau et al 2016</a>].</p><p><b>Other laboratory findings.</b> Bone marrow erythroid progenitor colonies exhibit EPO hypersensitivity.</p></div><div id="pfcp.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Given the small number of reported <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to date, it has not been possible to identify any <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>; however, it is notable that the age at diagnosis and the clinical findings vary even within the same family.</p></div><div id="pfcp.Penetrance"><h3>Penetrance</h3><p>Data are insufficient to draw any conclusions about <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p></div><div id="pfcp.Prevalence"><h3>Prevalence</h3><p>Primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP) is a rare disorder; the prevalence is not known. To date, PFCP caused by inherited <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>EPOR</i> has been reported in 116 individuals in 24 families [<a class="bk_pop" href="#pfcp.REF.bento.2014.15">Bento et al 2014</a>].</p></div></div><div id="pfcp.Genetically_Related_Allelic_Disorde"><h2 id="_pfcp_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>EPOR</i>.</p></div><div id="pfcp.Differential_Diagnosis"><h2 id="_pfcp_Differential_Diagnosis_">Differential Diagnosis</h2><p>Causes of erythrocytosis to be considered in the differential diagnosis of primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP) include:</p><ul><li class="half_rhythm"><div><b>Acquired primary erythrocytosis</b> (polycythemia vera due to a somatic <i>JAK2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>)</div></li><li class="half_rhythm"><div><b>Secondary erythrocytosis,</b> which can result from:</div><ul><li class="half_rhythm"><div>Events extrinsic to the erythroid compartment (e.g., cardiac or pulmonary insufficiency) which induce hypoxia and increase the production of EPO resulting in erythrocytosis;</div></li><li class="half_rhythm"><div>Inherited variants that result in high oxygen affinity of hemoglobin causing tissue hypoxia, such as:</div><ul><li class="half_rhythm"><div class="half_rhythm">Variants in <i>HBB</i> (encoding <a href="/books/n/gene/b-thal/">hemoglobin subunit beta</a>) (OMIM <a href="http://omim.org/entry/141900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">141900</a>) or <i>HBA1</i> (OMIM <a href="http://omim.org/entry/141800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">141800</a>) and HBA2 (OMIM <a href="http://omim.org/entry/141850" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">141850</a>) (encoding <a href="/books/n/gene/a-thal/">hemoglobin subunit alpha</a>);</div><div class="half_rhythm">OR</div></li><li class="half_rhythm"><div class="half_rhythm">Variants in <i>BPGM</i> that result in erythrocyte bisphosphoglycerate mutase (2,3- BPG) deficiency (OMIM <a href="http://omim.org/entry/222800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">222800</a>)<i>.</i></div></li></ul></li><li class="half_rhythm"><div>Inherited variants in some of the genes encoding oxygen-sensing pathway proteins, such as: <i>EGLN1</i>, <i>EPAS1</i>, and <a href="/books/n/gene/vhl/"><i>VHL</i></a> (reviewed in <a class="bk_pop" href="#pfcp.REF.bento.2014.15">Bento et al [2014]</a>; for diagnostic algorithms see <a class="bk_pop" href="#pfcp.REF.bento.2013.361">Bento et al [2013]</a> and <a class="bk_pop" href="#pfcp.REF.cario.2013.1734">Cario et al [2013]</a>).</div></li></ul></li></ul></div><div id="pfcp.Management"><h2 id="_pfcp_Management_">Management</h2><div id="pfcp.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div class="half_rhythm">Full blood counts with evaluation of white blood cells and of platelets, if not performed at the time of diagnosis</div></li><li class="half_rhythm"><div class="half_rhythm">Cardiology assessment including cardiac function (echocardiography) and blood pressure measurement. In case of increased blood pressure, perform 24-hour measurement.</div></li><li class="half_rhythm"><div class="half_rhythm">Recording of symptoms of hyperviscosity syndrome and their severity</div><div class="half_rhythm">Hyperviscosity syndrome symptoms:</div><ul><li class="half_rhythm"><div>Headache</div></li><li class="half_rhythm"><div>Dizziness</div></li><li class="half_rhythm"><div>Altered mentation, sense of distance</div></li><li class="half_rhythm"><div>Visual disturbances</div></li><li class="half_rhythm"><div>Tinnitus</div></li><li class="half_rhythm"><div>Paresthesia</div></li><li class="half_rhythm"><div>Low performance</div></li><li class="half_rhythm"><div>Fatigue, lassitude</div></li><li class="half_rhythm"><div>Myalgia, muscle weakness</div></li></ul><div class="half_rhythm">Hyperviscosity syndrome severity:</div><ul><li class="half_rhythm"><div>Grade 1. Mild; does not interfere with normal activities</div></li><li class="half_rhythm"><div>Grade 2. Moderate; interferes with some activities</div></li><li class="half_rhythm"><div>Grade 3. Marked to severe; interferes with most or all activities</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="pfcp.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No management guidelines have been published.</p><p>The majority of individuals with PFCP require no regular treatment.</p><p>In some individuals with PFCP, antihypertensive treatment and phlebotomies are initiated either:</p><ul><li class="half_rhythm"><div>When symptoms of the hyperviscosity syndrome are evident;</div><div>OR</div></li><li class="half_rhythm"><div>At routine intervals to maintain the hematocrit at an almost normal level.</div></li></ul><p>While low-dose aspirin can be considered for the prevention of thromboembolic events, no evidence of efficacy exists. Of note, at least one individual (a male age 40 yrs) died from myocardial infarction despite regularly performed phlebotomies [<a class="bk_pop" href="#pfcp.REF.prchal.1996.263">Prchal &#x00026; Sokol 1996</a>].</p><p><b>Hyperviscosity symptoms (see</b>
<a href="#pfcp.Evaluations_Following_Initial_Diagn"><b>Evaluations Following Initial Diagnosis</b></a><b>)</b></p><ul><li class="half_rhythm"><div>Grade 1. Consider aspirin treatment.</div></li><li class="half_rhythm"><div>Grade 2. Consider aspirin treatment. In the presence of persistent symptoms perform phlebotomy. In the event of recurrent episodes consider regular phlebotomy to maintain the hematocrit in the age-respective normal range.</div></li><li class="half_rhythm"><div>Grade 3. Consider regular phlebotomy to maintain hematocrit in the age-respective normal range. Consider additional aspirin treatment.</div></li></ul><p><b>Thromboembolic events</b></p><ul><li class="half_rhythm"><div>Provide acute treatment according to established practice for the event.</div></li><li class="half_rhythm"><div>Evaluate for other thrombophilic risk factors.</div></li><li class="half_rhythm"><div>Start regular phlebotomy to maintain hematocrit in the age-respective normal range. Consider additional aspirin treatment in all patients.</div></li><li class="half_rhythm"><div>Consider life-long anticoagulation (e.g., heparins, warfarin) when other severe additional risk factors are present or thromboembolic events have recurred.</div></li></ul></div><div id="pfcp.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>Always maintain good hydration.</p><p>Avoid activities that potentially increase blood viscosity (e.g., mountain climbing, scuba diving, smoking).</p><p>For those at increased risk for thromboembolic events: take precautions in higher-risk situations such as long-distance airline flights.</p></div><div id="pfcp.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Regular cardiology assessment including cardiac function (echocardiography) and blood pressure measurement. In case of occasionally increased blood pressure, perform 24-hour measurement.</div></li><li class="half_rhythm"><div>Regular life-long follow up with investigation of any suspicious clinical events such as thromboembolic complications and symptoms that could be related to hyperviscosity</div></li><li class="half_rhythm"><div>Regular life-long follow up to record manifestations of hyperviscosity syndrome and their severity (see <a href="#pfcp.Evaluations_Following_Initial_Diagn">Evaluations Following Initial Diagnosis</a>)</div></li></ul></div><div id="pfcp.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid:</p><ul><li class="half_rhythm"><div>Dehydration;</div></li><li class="half_rhythm"><div>Any activity that would potentially increase blood viscosity.</div></li></ul></div><div id="pfcp.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those with PFCP who would benefit from education regarding <a href="#pfcp.AgentsCircumstances_to_Avoid">agents and circumstances to avoid</a> and inappropriate treatments. Evaluations can include the following:</p><ul><li class="half_rhythm"><div><b>If the <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known.</b> Molecular genetic testing</div></li><li class="half_rhythm"><div><b>If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the family.</b> Blood count and serum EPO concentration if hemoglobin and hematocrit are increased</div></li></ul><p>See <a href="#pfcp.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pfcp.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No information is available on the management of pregnancy in a woman with PFCP.</p><p>Although the only survey of pregnancy in women with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> erythrocytosis did not include any women with an <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, data showed that when treated with low-dose aspirin and phlebotomy to reduce the hematocrit to a suitable level, women with erythrocytosis can have normal pregnancies and give birth to healthy children [<a class="bk_pop" href="#pfcp.REF.mcmullin.2015.586">McMullin et al 2015</a>].</p></div><div id="pfcp.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="pfcp.Genetic_Counseling"><h2 id="_pfcp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pfcp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Primary <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> polycythemia (PFCP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="pfcp.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with PFCP have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with PFCP may have the disorder as the result of a <i>de novo EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, the proportion of PFCP caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>If the <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (although no instances of germline mosaicism have been reported, it remains a possibility).</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include a complete blood count for determination of hemoglobin and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>EPOR</i> pathogenic variant identified in the proband.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with PFCP may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disorder in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%. However, because of the clinical variability observed in this disorder even within the same family, clinical findings and age at diagnosis cannot be predicted in sibs who inherit a pathogenic variant.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If the <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with PFCP has a 50% chance of inheriting the <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="pfcp.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#pfcp.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with PFCP has the <i>EPOR</i> pathogenic variant or clinical evidence of the disorder, the <i>EPOR</i> pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pfcp.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible. However, because of the clinical variability observed in PFCP even within the same family, molecular genetic test results cannot predict clinical findings or age at diagnosis.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="pfcp.Resources"><h2 id="_pfcp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/familial-erythrocytosis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Familial erythrocytosis</a></div></li><li class="half_rhythm"><div><b>European Congenital Erythrocytosis Consortium Registry</b></div><div><a href="http://www.erythrocytosis.org/scid/polycythemias_en/default.asp" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.erythrocytosis.org</a></div></li></ul></div><div id="pfcp.Molecular_Genetics"><h2 id="_pfcp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pfcp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Primary Familial and Congenital Polycythemia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK395975/table/pfcp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pfcp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pfcp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pfcp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pfcp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pfcp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pfcp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pfcp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pfcp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2057" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EPOR</i></a></td><td headers="hd_b_pfcp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2057" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pfcp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P19235" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Erythropoietin receptor</a></td><td headers="hd_b_pfcp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EPOR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EPOR database</a></td><td headers="hd_b_pfcp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EPOR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EPOR</a></td><td headers="hd_b_pfcp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EPOR[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EPOR</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pfcp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pfcp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Primary Familial and Congenital Polycythemia (<a href="/omim/133100,133171" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK395975/table/pfcp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pfcp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/133100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">133100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/133171" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">133171</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ERYTHROPOIETIN RECEPTOR; EPOR</td></tr></tbody></table></div></div><div id="pfcp.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><b>Gene structure.</b>
<i>EPOR</i> comprises eight coding exons. The primary transcript (<a href="/nuccore/NM_000121.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000121.3</a>) is 2459 nucleotides in length. Alternatively spliced forms of the EPO receptor have been identified, one of which has a truncated cytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. This shorter transcript is expressed at high levels in immature erythroid progenitor cells. In contrast, the expression of the full-length receptor increases as progenitor cells mature [<a class="bk_pop" href="#pfcp.REF.nakamura.1992.1138">Nakamura et al 1992</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK395975/#pfcp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>.</b> Three <i>EPOR</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (c.1310G&#x0003e;A, c.1462C&#x0003e;T, c.1460A&#x0003e;G) have been described for which the association with PFCP has not yet been clarified.</p><ul><li class="half_rhythm"><div>The c.1310G&#x0003e;A variant was described in a male age 35 years who required regular phlebotomy but also in a patient age 52 years with a clinical history of recurrent venous thrombosis, with normal hemoglobin and hematocrit levels and no <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> history of hematologic disorders [<a class="bk_pop" href="#pfcp.REF.bento.2013.361">Bento et al 2013</a>, <a class="bk_pop" href="#pfcp.REF.chauveau.2016.475">Chauveau et al 2016</a>].</div></li><li class="half_rhythm"><div>The c.1462C&#x0003e;T variant was found in a white male age 42 years with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> primary polycythemia and in his non-polycythemic mother [<a class="bk_pop" href="#pfcp.REF.sokol.1994.447">Sokol et al 1994</a>].</div></li></ul><p><b>Pathogenic variants.</b> To date, about 20 pathogenic variants have been described in association with PFCP with most (if not all) located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8, which encodes the C-terminal negative regulatory <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein. Pathogenic variants are mostly <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift variants (due to small intragenic deletions or insertions) that predict or result in cytoplasmic truncation of the receptor and loss of the C-terminal negative regulatory domain. Of note, not all the mechanisms by which pathogenic variants induce erythrocytosis are fully understood at present.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, c.1316G&#x0003e;A, identified in 29 individuals from one Finnish family was predicted to truncate the EPO receptor by 70 amino acids at the C-terminal cytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#pfcp.REF.de_la_chapelle.1993.4495">de la Chapelle et al 1993</a>]. The same variant was also identified as a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variant in an English boy [<a class="bk_pop" href="#pfcp.REF.percy.1998.407">Percy et al 1998</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, c.1317G&#x0003e;A, giving rise to the same amino acid substitution (p.Trp439Ter), was also identified as a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variant in a Spanish newborn [<a class="bk_pop" href="#pfcp.REF.rives.2007.674">Rives et al 2007</a>].</p><div id="pfcp.T.epor_variants_discussed_in_this_g" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>EPOR</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK395975/table/pfcp.T.epor_variants_discussed_in_this_g/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pfcp.T.epor_variants_discussed_in_this_g_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Uncertain significance</b></td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1310G&#x0003e;A</td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg437His</td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_4" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000121.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000121<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_000112.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000112<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1460A&#x0003e;G</td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn487Ser</td></tr><tr><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1462C&#x0003e;T</td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro488Ser</td></tr><tr><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1316G&#x0003e;A</td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp439Ter</td></tr><tr><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1317G&#x0003e;A</td><td headers="hd_h_pfcp.T.epor_variants_discussed_in_this_g_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp439Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> EPOR, a glycoprotein of about 60 kd and 508 amino acids which belongs to the cytokine class I receptor family, is a transmembrane receptor consisting of: an extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that changes conformation upon EPO binding, a hydrophobic transmembrane domain, and a cytoplasmic domain with eight tyrosine residues, serving as phosphorylation sites for proteins involved in downstream signal transduction [<a class="bk_pop" href="#pfcp.REF.lacombe.1999.22">Lacombe &#x00026; Mayeux 1999</a>].</p><p>EPOR dimerization activates cytoplasmic tyrosine Janus kinases 2 (JAK2) activity, enabling phosphorylation of some of the tyrosine residues present in the cytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of EPOR [<a class="bk_pop" href="#pfcp.REF.lodish.1992.95">Lodish et al 1992</a>, <a class="bk_pop" href="#pfcp.REF.witthuhn.1993.227">Witthuhn et al 1993</a>, <a class="bk_pop" href="#pfcp.REF.miura.1994.1501">Miura et al 1994</a>, <a class="bk_pop" href="#pfcp.REF.damen.1996.1455">Damen &#x00026; Krystal 1996</a>].</p><p>Following phosphorylation of EPOR, a number of other signal transduction proteins also become phosphorylated and initiation of the signal transduction pathways occurs. One such signal transducer and activator of transcription, the protein STAT5, binds to phosphorylated tyrosine present on the cytoplasmic tail of EPOR and itself becomes phosphorylated at the level of tyrosine residues [<a class="bk_pop" href="#pfcp.REF.damen.1995.5557">Damen et al 1995</a>, <a class="bk_pop" href="#pfcp.REF.gobert.1996.2434">Gobert et al 1996</a>].</p><p>Phosphorylated STAT5 dissociates from the receptor, dimerizes, and is translocated from the cytoplasm to the nucleus, where it activates the expression of several anti-apoptotic genes in erythroid cells, most notably <i>BCL2L1,</i> through a direct binding at the level of STAT5-binding consensus sequences present in the promoter of <i>BCL2L1.</i></p><p>These effects of STAT5 on <i>BCL2L1</i> activation provide the molecular basis of the anti-apoptotic effects elicited by STAT5 in erythroid cell lines [<a class="bk_pop" href="#pfcp.REF.nosaka.1999.4754">Nosaka et al 1999</a>, <a class="bk_pop" href="#pfcp.REF.socolovsky.1999.181">Socolovsky et al 1999</a>, <a class="bk_pop" href="#pfcp.REF.james.2005.546">James et al 2005</a>].</p><p>Control of intensity and duration of EPO-EPOR signaling is necessary to tightly regulate erythropoiesis. An ubiquitin/proteasome system plays the major role in the control of EPOR signaling. After EPO binding, EPOR is ubiquitinated and the intracellular part is degraded by the proteasome, preventing further signal transduction. The remaining part of the receptor and associated EPO are internalized and degraded by the lysosomes [<a class="bk_pop" href="#pfcp.REF.meyer.2007.5215">Meyer et al 2007</a>]. The binding of p85, the regulatory subunit of phosphoinositide 3-kinase (PI3K), to phosphorylated residues Tyr429, Tyr431, or Tyr479, located in the C-terminal site of the cytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of EPOR, plays an important role in EPO-dependent EPOR internalization.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in the cytoplasmic portion of EPOR identified in persons with PFCP result in truncated EPORs lacking the cytoplasmic COOH-terminal of the receptor, which contains a negative regulatory <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and is essential in SHP-1 phosphatase binding (a negative regulator of EPOR signaling). The lack of downregulation of EPOR after ligand binding results in increased proliferation rates due to the prolonged activation of JAK2-STAT5 and other signaling cascades and is responsible for the EPO hypersensitivity of erythroid progenitors observed in vitro in persons with PFCP [<a class="bk_pop" href="#pfcp.REF.huang.2010.844">Huang et al 2010</a>].</p><p>Using epidermal growth factor receptor-EPOR chimeras, <a class="bk_pop" href="#pfcp.REF.gross.2014.519">Gross et al [2014]</a> recently described higher proliferation rates of UT7 cells associated with all <i>EPOR</i> pathogenic variants, including <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants.</p></div></div><div id="pfcp.References"><h2 id="_pfcp_References_">References</h2><div id="pfcp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.alsheikh.2008.1072">Al-Sheikh M, Mazurier E, Gardie B, Casadevall N, Galact&#x000e9;ros F, Goossens M, Wajcman H, Pr&#x000e9;hu C, Ugo V. A study of 36 unrelated cases with pure erythrocytosis revealed three new mutations in the erythropoietin receptor gene. <span><span class="ref-journal">Haematologica. </span>2008;<span class="ref-vol">93</span>:1072–5.</span> [<a href="/pubmed/18492694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18492694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.arcasoy.1997.4628">Arcasoy MO, Degar BA, Harris KW, Forget BG. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. <span><span class="ref-journal">Blood. </span>1997;<span class="ref-vol">89</span>:4628–35.</span> [<a href="/pubmed/9192789" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9192789</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.bento.2013.361">Bento C, Almeida H, Maia TM, Relvas L, Oliveira AC, Rossi C, Girodon F, Fernandez-Lago C, Aguado-Diaz A, Fraga C, Costa RM, Ara&#x000fa;jo AL, Silva J, Vit&#x000f3;ria H, Miguel N, Silveira MP, Martin-Nu&#x000f1;ez G, Ribeiro ML. <span><span class="ref-journal">Eur J Haematol. </span>2013;<span class="ref-vol">91</span>:361–8.</span> [<a href="/pubmed/23859443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23859443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.bento.2014.15">Bento C, Percy MJ, Gardie B, Maia TM, van Wijk R, Perrotta S, Della Ragione F, Almeida H, Rossi C, Girodon F, Astr&#x000f6;m M, Neumann D, Schnittger S, Landin B, Minkov M, Randi ML, Richard S, Casadevall N, Vainchenker W, Rives S, Hermouet S, Ribeiro ML, McMullin MF, Cario H., ECE-Consortium.  Chauveau A, Gimenez-Roqueplo AP, Bressac-de-Paillerets B, Altindirek D, Lorenzo F, Lambert F, Dan H, Gad-Lapiteau S, Catarina Oliveira A, Rossi C, Fraga C, Taradin G, Martin-Nu&#x000f1;ez G, Vit&#x000f3;ria H, Diaz Aguado H, Palmblad J, Vid&#x000e1;n J, Relvas L, Ribeiro ML, Luigi Larocca M, Luigia Randi M, Pedro Silveira M, Percy M, Gross M, Marques da Costa R, Beshara S, Ben-Ami T, Ugo V; ECE-Consortium. Genetic basis of congenital erythrocytosis: mutation update and online databases. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:15–26.</span> [<a href="/pubmed/24115288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24115288</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.bourantas.2006.537">Bourantas LK, Chatzikyriakidou A, Dasoula A, Syrrou M, Bournatas KL, Georgiou I. Absence of mutations of the EPO-receptor gene in Greek patients with familial polycythemia. <span><span class="ref-journal">Eur J Haematol. </span>2006;<span class="ref-vol">76</span>:537–8.</span> [<a href="/pubmed/16608505" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16608505</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.cario.2013.1734">Cario H, McMullin F, Bento C, Pospisilova D, Percy MJ, Hussein K, Schwarz J, Astr&#x000f6;m M, Hermouet S. MPN&#x00026;MPNr-EuroNet. Erythrocytosis in children and adolescents - classification, characterization, and consensus recommendations for the diagnostic approach. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2013;<span class="ref-vol">60</span>:1734–8.</span> [<a href="/pubmed/23776154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23776154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.chauveau.2016.475">Chauveau A, Luque Paz D, Lecucq L, Le Gac G, Le Mar&#x000e9;chal C, Gueguen P, Berthou C, Ugo V. A new point mutation in EPOR inducing a short deletion in congenital erythrocytosis. <span><span class="ref-journal">Br J Haematol. </span>2016;<span class="ref-vol">172</span>:475–7.</span> [<a href="/pubmed/26010769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26010769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.damen.1996.1455">Damen JE, Krystal G. Early events in erythropoietin-induced signaling. <span><span class="ref-journal">Exp Hematol. </span>1996;<span class="ref-vol">24</span>:1455.</span> [<a href="/pubmed/8950227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8950227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.damen.1995.5557">Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL, Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and STAT5 activation. <span><span class="ref-journal">EMBO J. </span>1995;<span class="ref-vol">14</span>:5557.</span> [<a href="/pmc/articles/PMC394670/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC394670</span></a>] [<a href="/pubmed/8521813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8521813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.de_la_chapelle.1993.4495">de la Chapelle A, Traskelin AL, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1993;<span class="ref-vol">90</span>:4495–9.</span> [<a href="/pmc/articles/PMC46538/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC46538</span></a>] [<a href="/pubmed/8506290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8506290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.furukawa.1997.222">Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M, Azegami T, Kishi K, Takahashi M, Utsumi J, Koike T, Aizawa Y. Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor. <span><span class="ref-journal">Br J Haematol. </span>1997;<span class="ref-vol">99</span>:222–7.</span> [<a href="/pubmed/9359528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9359528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.gobert.1996.2434">Gobert S, Chretien S, Gouilleux F, Muller O, Pallard C. Dusanter- Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. <span><span class="ref-journal">EMBO J. </span>1996;<span class="ref-vol">15</span>:2434.</span> [<a href="/pmc/articles/PMC450175/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC450175</span></a>] [<a href="/pubmed/8665851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8665851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.gross.2014.519">Gross M, Ben-Califa N, McMullin MF, Percy MJ, Bento C, Cario H, Minkov M, Neumann D. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor - EPOR chimeras. <span><span class="ref-journal">Br J Haematol. </span>2014;<span class="ref-vol">165</span>:519–28.</span> [<a href="/pubmed/24533580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24533580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.huang.2010.844">Huang LJ, Shen YM, Bulut GB. Advances in understanding the pathogenesis of primary familial and congenital polycythaemia. <span><span class="ref-journal">Br J Haematol. </span>2010;<span class="ref-vol">148</span>:844–52.</span> [<a href="/pmc/articles/PMC2864346/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2864346</span></a>] [<a href="/pubmed/20096014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20096014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.james.2005.546">James C, Ugo V, Casadevall N, Constantinescu SN, Vainchenker W. A. JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. <span><span class="ref-journal">Trends Mol Med. </span>2005;<span class="ref-vol">11</span>:546–54.</span> [<a href="/pubmed/16271512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16271512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.jedlickova.2003.327">Jedlickova K, Stockton DW, Prchal JT. Possible primary familial and congenital polycythemia locus at 7q22.1-7q22.2. <span><span class="ref-journal">Blood Cells Mol Dis. </span>2003;<span class="ref-vol">31</span>:327–31.</span> [<a href="/pubmed/14636647" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14636647</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.kralovics.1997.2057">Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. <span><span class="ref-journal">Blood. </span>1997;<span class="ref-vol">90</span>:2057–61.</span> [<a href="/pubmed/9292543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9292543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.kralovics.2001.115">Kralovics R, Prchal JT. Genetic heterogeneity of primary familial and congenital polycythemia. <span><span class="ref-journal">Am J Hematol. </span>2001;<span class="ref-vol">68</span>:115–21.</span> [<a href="/pubmed/11559951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11559951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.kralovics.1998.124">Kralovics R, Sokol L, Prchal JT. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. <span><span class="ref-journal">J Clin Invest. </span>1998;<span class="ref-vol">102</span>:124–9.</span> [<a href="/pmc/articles/PMC509073/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC509073</span></a>] [<a href="/pubmed/9649565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9649565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.lacombe.1999.22">Lacombe C, Mayeux P. The molecular biology of erythropoietin. <span><span class="ref-journal">Nephrol Dial Transplant. </span>1999;<span class="ref-vol">14</span> Suppl 2:22–8.</span> [<a href="/pubmed/10334664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10334664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.lodish.1992.95">Lodish HF, Hilton D, Longmore G, Watowich SS, Yoshimura A. The erythropoietin receptor: dimerization, activation, and tumorigenesis. <span><span class="ref-journal">Cold Spring Harb Symp Quant Biol. </span>1992;<span class="ref-vol">57</span>:95–106.</span> [<a href="/pubmed/1339709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1339709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.mcmullin.2005.174">McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, Wilkins B., General Haematology Task Force of the British Committee for Standards in Haematology.  Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. <span><span class="ref-journal">Br J Haematol. </span>2005;<span class="ref-vol">130</span>:174–95.</span> [<a href="/pubmed/16029446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16029446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.mcmullin.2015.586">McMullin MF, Bento C, Rossi C, Rainey MG, Girodon F, Cario H. Outcomes of pregnancy in patients with congenital erythrocytosis. <span><span class="ref-journal">Br J Haematol. </span>2015;<span class="ref-vol">170</span>:586–8.</span> [<a href="/pubmed/25732921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25732921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.mcmullin.2016.248">McMullin MF, Cario H. LNK mutations and myeloproliferative disorders. <span><span class="ref-journal">Am J Hematol. </span>2016;<span class="ref-vol">91</span>:248–51.</span> [<a href="/pubmed/26660394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26660394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.meyer.2007.5215">Meyer L, Deau B, Forejtnikova H, Dumenil D, Margottin-Goguet F, Lacombe C, Mayeux P, Verdier F. Beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:5215–22.</span> [<a href="/pubmed/17327410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17327410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.miura.1994.1501">Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ilhe JN, Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor. <span><span class="ref-journal">Blood. </span>1994;<span class="ref-vol">84</span>:1501.</span> [<a href="/pubmed/8068943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8068943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.nakamura.1992.1138">Nakamura Y, Komatsu N, Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. <span><span class="ref-journal">Science. </span>1992;<span class="ref-vol">257</span>:1138–41.</span> [<a href="/pubmed/1324524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1324524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.nosaka.1999.4754">Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL, Kitamura T. Stat5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. <span><span class="ref-journal">EMBO J. </span>1999;<span class="ref-vol">18</span>:4754–65.</span> [<a href="/pmc/articles/PMC1171548/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1171548</span></a>] [<a href="/pubmed/10469654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10469654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.percy.1998.407">Percy MJ, McMullin MF, Roques AW, Westwood NB, Acharya J, Hughes AE, Lappin TR, Pearson TC. Erythrocytosis due to a mutation in the erythropoietin receptor gene. <span><span class="ref-journal">Br J Haematol. </span>1998;<span class="ref-vol">100</span>:407–10.</span> [<a href="/pubmed/9488636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9488636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.petersen.2004.537">Petersen KB, Hokland P, Petersen GB, Nyvold CG. Erythropoietin receptor defect: a cause of primary polycythemia. <span><span class="ref-journal">Br J Haematol. </span>2004;<span class="ref-vol">125</span>:537–8.</span> [<a href="/pubmed/15142125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15142125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.prchal.1985.1208">Prchal JT, Crist WM, Goldwasser E, Perrine G, Prchal JF. Autosomal dominant polycythemia. <span><span class="ref-journal">Blood. </span>1985;<span class="ref-vol">66</span>:1208–14.</span> [<a href="/pubmed/4052634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4052634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.prchal.1995.1831">Prchal JT, Semenza GL, Prchal J, Sokol L. Familial polycythemia. <span><span class="ref-journal">Science. </span>1995;<span class="ref-vol">268</span>:1831–2.</span> [<a href="/pubmed/7604250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7604250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.prchal.1996.263">Prchal JT, Sokol L. "Benign erythrocytosis" and other familial and congenital polycythemias. <span><span class="ref-journal">Eur J Haematol. </span>1996;<span class="ref-vol">57</span>:263–8.</span> [<a href="/pubmed/8982288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8982288</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.rives.2007.674">Rives S, Pahl HL, Florensa L, Bellosillo B, Neusuess A, Estella J, Debatin KM, Kohne E, Schwarz K, Cario H. Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis. <span><span class="ref-journal">Haematologica. </span>2007;<span class="ref-vol">92</span>:674–7.</span> [<a href="/pubmed/17488692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17488692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.socolovsky.1999.181">Socolovsky M, Fallon AEJ, Wang S, Brugnara C, Lodish HF. Fetal anemia and apoptosis of red cell progenitors in Stat5a/5b mice, a direct role for Stat5 in Bcl-XL induction. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">98</span>:181–91.</span> [<a href="/pubmed/10428030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10428030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.sokol.1995.15">Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. <span><span class="ref-journal">Blood. </span>1995;<span class="ref-vol">86</span>:15–22.</span> [<a href="/pubmed/7795221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7795221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.sokol.1994.447">Sokol L, Prchal JF, D&#x02019;Andrea A, Rado TA, Prchal JT. Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. <span><span class="ref-journal">Exp Hematol. </span>1994;<span class="ref-vol">22</span>:447–53.</span> [<a href="/pubmed/8174675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8174675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pfcp.REF.witthuhn.1993.227">Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. <span><span class="ref-journal">Cell. </span>1993;<span class="ref-vol">74</span>:227–36.</span> [<a href="/pubmed/8343951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8343951</span></a>]</div></li></ul></div></div><div id="pfcp.Chapter_Notes"><h2 id="_pfcp_Chapter_Notes_">Chapter Notes</h2><div id="pfcp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 November 2016 (bp) Review posted live</div></li><li class="half_rhythm"><div>21 October 2015 (ch) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK395975</span><span class="label">PMID: <a href="/pubmed/27831681" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">27831681</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/glc/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bgc/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK395975&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK395975/?report=reader">PubReader</a></li><li><a href="/books/NBK395975/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK395975" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK395975" style="display:none" title="Cite this Page"><div class="bk_tt">Bento C, McMullin MF, Percy M, et al. Primary Familial and Congenital Polycythemia. 2016 Nov 10. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK395975/pdf/Bookshelf_NBK395975.pdf">PDF version of this page</a> (441K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pfcp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pfcp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pfcp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pfcp.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pfcp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pfcp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pfcp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pfcp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pfcp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pfcp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pfcp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10019[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SH2B3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3717[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">JAK2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2057[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EPOR</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4338682" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4338682" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4338682" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4338682" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/8982288" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> "Benign erythrocytosis" and other familial and congenital polycythemias.</a><span class="source">[Eur J Haematol. 1996]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> "Benign erythrocytosis" and other familial and congenital polycythemias.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Prchal JT, Sokol L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Haematol. 1996 Oct; 57(4):263-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301424" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Dominant</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Dominant<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Harris PC, Torres VE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/9292543" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.</a><span class="source">[Blood. 1997]</span><div class="brieflinkpop offscreen_noflow">Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Blood. 1997 Sep 1; 90(5):2057-61. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301312" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Loeys BL, Dietz HC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/14636647" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Possible primary familial and congenital polycythemia locus at 7q22.1-7q22.2.</a><span class="source">[Blood Cells Mol Dis. 2003]</span><div class="brieflinkpop offscreen_noflow">Possible primary familial and congenital polycythemia locus at 7q22.1-7q22.2.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jedlickova K, Stockton DW, Prchal JT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Blood Cells Mol Dis. 2003 Nov-Dec; 31(3):327-31. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27831681" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27831681" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04139175f66d18aa09266e">Primary Familial and Congenital Polycythemia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Primary Familial and Congenital Polycythemia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:57:37-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C13A1E04081E10000000004AF01B5&amp;ncbi_session=CE8C13A1E0413901_1199SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK395975%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK395975&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK395975/&amp;ncbi_pagename=Primary Familial and Congenital Polycythemia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C13A1E0413901_1199SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>